我国医联体诊疗现状研究

Current status of diagnosis and treatment of medical consortium in China

医联体在慢性病的健康管理中具有明显优势,为慢性病的管理、防治提供科学依据。恶性肿瘤作为慢性病的一种,建立恶性肿瘤医联体有助于合理分配医疗资源、科学构建医疗服务体系,是缓解百姓看病难、住院难的有效形式。双向转诊、分级诊疗制度是医联体建设的重点。区域医联体建设实践中,提高了肿瘤专业诊疗服务能力和水平,制度仍需改进。结合国内外医联体建设情况,提出完善国内医联体系建设的建议,以期实现政府、医院、社会、患者多方共赢。

Regional medical consortium has remarkable advantages in health management of chronic diseases, and it provides scientific references tor management and prevention of chronic diseases. Malignant tumor is a kind of chrunic diseases. The medical consortium of malignant tumor contributes to the reasonable distribution of medical resources and the scientific system of medical service. The establishment of medical consortium of malignant tumor alleviates the difficulty of getting medical service and being in hospital to patients. The emphasis on constructing medieal consortium is dual referral system and hierarchical hospital visit system. The practice of regional medical consortium improved the capacity and level of diagnosis and treatment of tumor, but the system still needs to be improved. Based on the construetion condition of medical consortium at home and abroad, the suggestion to perfect domestic medical consortium system rewards to realizing an all-win result among government, hospital, society, and patients.